Bokström H, Bryman I, Norström A, Platz-Christensen J J
Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Int J Gynaecol Obstet. 1995 Jan;48(1):69-74. doi: 10.1016/0020-7292(94)02258-5.
To compare a new regimen for second trimester abortion using Dilapan and vaginal gemeprost suppositories with extra-amniotic Rivanol instillation and oxytocin i.v. immediately or 16 h after instillation.
A prospective study was performed in 153 women to analyze the induction-abortion interval, the use of analgesics and the complication rate. Wilcoxon's rank sum test was used for statistical evaluation.
The mean induction-abortion interval was significantly shorter in the Dilapan-gemeprost-treated women than in the immediate or 16-h Rivanol-oxytocin-treated women, 12.5 vs. 23.3 and 26.8 h, respectively. The 24-h cumulative abortion rate was 91% in the former group vs. 49% and 61%, respectively. The use of analgesics was less frequent among the Dilapan-gemeprost-treated women, whereas the complication rate did not differ.
The Dilapan-gemeprost treatment was advantageous with respect to a shorter induction-abortion interval and ease of handling. However a minority of women do not respond to this treatment and it is therefore necessary to employ alternative methods to complete the abortion in these cases.
比较使用狄拉朋(Dilapan)和阴道用吉美前列素栓剂进行中期引产的新方案与羊膜外利凡诺尔注入联合静脉注射催产素(注入后立即或16小时后)的效果。
对153名女性进行前瞻性研究,分析引产至流产的间隔时间、镇痛药的使用情况及并发症发生率。采用Wilcoxon秩和检验进行统计学评估。
接受狄拉朋 - 吉美前列素治疗的女性引产至流产的平均间隔时间明显短于立即接受利凡诺尔 - 催产素治疗或注入利凡诺尔16小时后接受利凡诺尔 - 催产素治疗的女性,分别为12.5小时、23.3小时和26.8小时。前一组的24小时累积流产率为91%,而后两组分别为49%和61%。接受狄拉朋 - 吉美前列素治疗的女性使用镇痛药的频率较低,而并发症发生率无差异。
狄拉朋 - 吉美前列素治疗在缩短引产至流产间隔时间和操作简便方面具有优势。然而,少数女性对此治疗无反应,因此在这些情况下有必要采用其他方法来完成流产。